# NRx Pharmaceuticals, Inc. (NRXP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NRXP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 2.17M | $ -17.95M | $ -14.07M | N/A | $ -170.0K |
| 2025 | $ 1.25M | $ -29.31M | $ -14.45M | N/A | $ -15.94M |
| 2024 | $ 0 | $ -26.41M | $ -12.17M | N/A | $ -23.22M |
| 2023 | $ 0 | $ -32.60M | $ -23.42M | N/A | $ -11.73M |
| 2022 | $ 0 | $ -44.41M | $ -44.41M | N/A | $ 7.41M |
| 2021 | $ 0 | $ -111.08M | $ -44.83M | N/A | $ 20.81M |
| 2020 | $ 0 | $ -63.59M | $ -2.89M | N/A | $ -43.77M |
| 2019 | $ 0 | $ 527.2K | $ -1.02M | N/A | $ 29.50M |
| 2018 | $ 0 | $ 87.3K | $ -624.9K | N/A | $ 69.54M |
| 2017 | $ 0 | $ -141.4K | $ -183.0K | $ 0 | $ 69.47M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | -201.94 |
| Current Ratio | 0.86 |

## Other views

- [Metrics](https://sponda.capital/en/NRXP.md)
- [Charts](https://sponda.capital/en/NRXP/charts.md)
- [Compare](https://sponda.capital/en/NRXP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.